Trial Profile
Randomized, double-blind, multicentre, outpatient trial of risperidone in patients with treatment resistant Schizophrenia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Oct 2015
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 14 Oct 2015 New trial record